DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Caplin ME. et al.
Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.
Endocr Relat Cancer 2016;
23: 191-199
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.